\
&
Contact us
\
&
Contact us
Horizon Europe & Digital Europe offer a broad range of funding opportunities which you can discover by searching the Commission’s Funding & Tenders Opportunities Portal.
On the dedicated pages on our website for each of the subprogrammes under Horizon Europe or Digital Europe, you can find a direct link to the open & forthcoming calls of the programme part of your choice. On these pages, you can also find the relevant info on the most recent Commission Information Day held to inform stakeholders about open & forthcoming calls.
For Horizon Europe, all information on past and upcoming Commission Info Days is bundled here.
A bit lost in the complexity of the programmes? We are there to help. We can offer guidance on:
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
